Related Experiment Videos
Elevated vascular endothelial growth factor production in islets improves islet graft vascularization
Nan Zhang1, Anja Richter, Jenny Suriawinata
1Carl Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
Diabetes
|March 30, 2004
Summary
Vascular endothelial growth factor (VEGF) gene delivery to transplanted islets enhances revascularization and improves blood glucose control in diabetic mice. This strategy promotes islet graft survival and function.
Area of Science:
- Endocrinology
- Vascular Biology
- Transplantation Immunology
Background:
- Islet transplantation success relies on sufficient graft revascularization.
- Delayed vascularization leads to islet cell death and graft failure.
- Enhancing blood vessel formation is critical for islet graft survival.
Purpose of the Study:
- To investigate if vascular endothelial growth factor (VEGF) delivery can improve islet revascularization and function post-transplantation.
- To assess the impact of VEGF on islet graft survival and glucose homeostasis in diabetic mice.
Main Methods:
- Murine islets were transduced with human VEGF cDNA or a control vector.
- Transduced islets were transplanted under the renal capsule of diabetic mice.
- Graft revascularization, insulin content, and blood glucose levels were analyzed.
Main Results:
- VEGF-transduced islets showed significantly improved revascularization and higher insulin content.
- Diabetic mice transplanted with VEGF islets achieved near-normoglycemia.
- Control islets resulted in persistent hyperglycemia.
Conclusions:
- VEGF production by islets stimulates graft angiogenesis and enhances revascularization.
- VEGF gene therapy is a promising strategy to improve islet graft survival and function.
- Accelerating revascularization can enhance long-term islet graft success.